Increased designer drug introduction has put more pressure on the law enforcement agencies to quickly identify these compounds. Advancements in the mass spectrometry based assays have helped identify these compounds.
In this webinar Dr. Jean-Claude Alvarez, Professor of Medicine in Pharmacology at the University Versailles Saint Quentin-en-Yvelines explains how he and his team of experts analyze designer drugs in various matrices with MS techniques.
United States
